发明名称 |
THERAPEUTIC USES OF BETA-CASEIN A2 AND DIETARY SUPPLEMENT CONTAINING BETA-CASEIN A2 |
摘要 |
A method of reducing the serum level in a mammal of any one more cholesterol, low density lipoprotein (LDL) cholesterol relative to high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, very low density lipoprotein (VLDL) cholesterol, apolipoprotein B, and triglycerides by the ingestion of a composition containing beta-casein A<SUP>2</SUP>. A dietary supplement formed by the addition of beta-casein to a food or drink for human consumption where the beta-casein is comprised of at least 95% beta-casein A<SUP>2</SUP>, preferably solely beta-casein A<SUP>2</SUP>. |
申请公布号 |
EP1562629(A4) |
申请公布日期 |
2007.08.29 |
申请号 |
EP20030770160 |
申请日期 |
2003.10.03 |
申请人 |
A2 CORPORATION LIMITED |
发明人 |
CAMPBELL, JULIE HAZEL;TAILFORD, KRISTY ANN;MCLACHLAN, ULRIKE HF;MCLACHLAN, ULRIKE |
分类号 |
A23L1/305;A61K38/17;A61P9/10 |
主分类号 |
A23L1/305 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|